In 2013, at age 25, Elizabeth Pfiester founded T1International to address the global insulin price crisis as a type 1 diabetes patient. Over the years, the organization has successfully influenced insulin manufacturers to lower prices and advocated for policy changes. Pfiester emphasizes the need for patients to lead the fight against Big Pharma, rather than collaborating with them. T1International prioritizes ethical patient engagement and aims to empower patients to advocate for themselves. Pfiester is stepping down as executive director, confident that the organization and patient leaders within the diabetes community will continue the fight for affordable insulin.
Source link
How to take on Big Pharma and win
